• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600

    8/17/23 6:48:00 PM ET
    $DLB
    $REG
    $SPGI
    $STAA
    Multi-Sector Companies
    Miscellaneous
    Real Estate Investment Trusts
    Real Estate
    Get the next $DLB alert in real time by email

    NEW YORK, Aug. 17, 2023 /PRNewswire/ -- Dolby Laboratories Inc. (NYSE:DLB) will replace Staar Surgical Co. (NASD:STAA) in the S&P MidCap 400 and Staar Surgical will replace Urstadt Biddle Properties Inc. (NYSE:UBA) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, August 22. S&P 500 constituent Regency Centers Corp. (NASD: REG) will acquire Urstadt Biddle Properties in a transaction expected to close soon pending final closing conditions. Staar Surgical is more representative of the small-cap market space. 

    Following is a summary of the changes that will take place prior to the open of trading on the effective date: 

    Effective Date

    Index Name       

    Action

    Company Name

    Ticker

    GICS Sector

    August 22, 2023

    S&P MidCap 400

    Addition

    Dolby Laboratories

    DLB

    Information Technology



    S&P MidCap 400

    Deletion

    Staar Surgical

    STAA

    Health Care



    S&P SmallCap 600

    Addition

    Staar Surgical

    STAA

    Health Care



    S&P SmallCap 600

    Deletion

    Urstadt Biddle Properties

    UBA

    Real Estate

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES 

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected] 

    Media Inquiries

    [email protected] 

    Cision View original content:https://www.prnewswire.com/news-releases/dolby-laboratories-set-to-join-sp-midcap-400-staar-surgical-to-join-sp-smallcap-600-301904140.html

    SOURCE S&P Dow Jones Indices

    Get the next $DLB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DLB
    $REG
    $SPGI
    $STAA

    CompanyDatePrice TargetRatingAnalyst
    S&P Global Inc.
    $SPGI
    2/17/2026$575.00Buy
    BofA Securities
    STAAR Surgical Company
    $STAA
    2/3/2026$26.00Neutral
    Wedbush
    Regency Centers Corporation
    $REG
    1/20/2026$83.00Hold → Buy
    Deutsche Bank
    STAAR Surgical Company
    $STAA
    1/16/2026$13.00Underweight
    Morgan Stanley
    Regency Centers Corporation
    $REG
    1/9/2026$74.00Outperform → Neutral
    Mizuho
    Regency Centers Corporation
    $REG
    12/18/2025$76.00Overweight → Neutral
    Analyst
    Regency Centers Corporation
    $REG
    12/4/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Regency Centers Corporation
    $REG
    11/18/2025$82.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $DLB
    $REG
    $SPGI
    $STAA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on S&P Global with a new price target

    BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $575.00

    2/17/26 7:30:15 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Wedbush initiated coverage on STAAR Surgical with a new price target

    Wedbush initiated coverage of STAAR Surgical with a rating of Neutral and set a new price target of $26.00

    2/3/26 8:08:13 AM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Regency Centers upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Regency Centers from Hold to Buy and set a new price target of $83.00

    1/20/26 8:14:24 AM ET
    $REG
    Real Estate Investment Trusts
    Real Estate

    $DLB
    $REG
    $SPGI
    $STAA
    SEC Filings

    View All

    STAAR Surgical Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - STAAR SURGICAL CO (0000718937) (Filer)

    3/3/26 4:05:29 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    SEC Form 10-K filed by STAAR Surgical Company

    10-K - STAAR SURGICAL CO (0000718937) (Filer)

    3/3/26 3:58:10 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Regency Centers Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - REGENCY CENTERS CORP (0000910606) (Filer)

    3/2/26 12:23:53 PM ET
    $REG
    Real Estate Investment Trusts
    Real Estate

    $DLB
    $REG
    $SPGI
    $STAA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Joly Hubert bought $997,459 worth of shares (2,500 units at $398.98), increasing direct ownership by 1,515% to 2,665 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    2/12/26 4:01:28 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    President, S&P Global Mobility Eager William W bought $11,917 worth of shares (23 units at $517.58), increasing direct ownership by 0.26% to 8,724 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    1/15/26 4:01:18 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Large owner Broadwood Partners, L.P. bought $606,138 worth of shares (27,485 units at $22.05) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    1/13/26 9:30:12 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $DLB
    $REG
    $SPGI
    $STAA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by EVP, Chief Client Officer Moore Sally

    4 - S&P Global Inc. (0000064040) (Issuer)

    3/3/26 4:09:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by President, Market Intelligence Saha Saugata

    4 - S&P Global Inc. (0000064040) (Issuer)

    3/3/26 4:09:46 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by President, S&P Global Ratings Le Pallec Yann

    4 - S&P Global Inc. (0000064040) (Issuer)

    3/3/26 4:08:08 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $DLB
    $REG
    $SPGI
    $STAA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    STAAR Surgical Issues Shareholder Letter

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued a Shareholder Letter on Tuesday, March 3 after the market close. STAAR's results release can be found here: https://investors.staar.com/news-and-events/press-releases. Fellow Shareholders, This past month marked an important transition for our company as we stepped into the roles of Interim co-Chief Executive Officers. We are honored by the Board's confidence and deeply grateful for the dedication of our employees, the loyalty of our customers, and the opportunity to serve you—our shareholders. It is with great pleasure

    3/3/26 4:02:00 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results

    Confident in China Progress and Future Roadmap A Clear Path Toward Sustainable Profitability and Growth Board and Leadership Transitions Support Strategy Execution and Shareholder Value Creation STAAR Interim co-CEOs Issue Letter to Shareholders Earnings Call and Webcast Today at 5:30 PM Eastern STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal year ended January 2, 2026. STAAR's Interim co-CEOs will be issuing a Letter to Shareholders after this earnings release, which can be found here: https://investors.staar.com/new

    3/3/26 4:01:00 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Platts Launches 1st-of-type Power Purchase Agreement Price Assessments - Powered by REsurety's CleanTrade -- for North American Renewable Power Markets and New Monthly S&P Global Energy North American PPA Report

    Enhances Transparency as PPA Use Expands Amid Rising Clean Energy Demand, Rising Power Needs, and Policy UncertaintyNEW YORK and HOUSTON and BOSTON, March 3, 2026 /PRNewswire/ -- S&P Global Energy, the leading independent provider of information, analytics and benchmark prices for the commodities, energy, and energy expansion and transition markets, announced it has launched first-of-kind daily Power Purchase Agreement (PPA) price assessments for North American renewable power markets and an accompanying monthly S&P Global Energy North American PPA Report. The transparent Platts

    3/3/26 1:52:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $DLB
    $REG
    $SPGI
    $STAA
    Leadership Updates

    Live Leadership Updates

    View All

    S&P Global Appoints Chief Strategy Officer for Mobility Global Completing New Executive Leadership Team

    Martin Metzker to lead Strategy, Communications and Enterprise Marketing for Mobility Global in preparation for its planned separation into a standalone public companyNEW YORK, Feb. 19, 2026 /PRNewswire/ -- S&P Global (NYSE: SPGI) today announced the appointment of Martin Metzker as Chief Strategy Officer of S&P Global Mobility ("Mobility Global"), effective immediately. Mr. Metzker will be responsible for leading Mobility Global's Strategy function and overseeing Communications and Enterprise marketing for the business as it prepares for its planned separation from S&P Global into a standalone public company. Mr. Metzker joins the company from Boston Consulting Group, and will report to Bil

    2/19/26 4:15:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    RingCentral Set to Join S&P SmallCap 600

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- RingCentral Inc. (NYSE:RNG) will replace Hillenbrand Inc. (NYSE:HI) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 12. Lone Star Funds is acquiring Hillenbrand in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Feb 12, 2026 S&P SmallCap 600 Addition RingCentral RNG Information Technology Feb 12, 2026 S&P SmallCap 600 Deletion Hillenbrand HI Industrials ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the large

    2/9/26 6:08:00 PM ET
    $HI
    $RNG
    $SPGI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    EDP Services
    Technology

    Merchants Bancorp Set to Join S&P SmallCap 600

    NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Merchants Bancorp (NASD: MBIN) will replace TreeHouse Foods Inc. (NYSE:THS) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 11. Investindustrial S.A. and its affiliates are acquiring Treehouse Foods in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Feb 11, 2026 S&P SmallCap 600 Addition Merchants Bancorp MBIN Financial Feb 11, 2026 S&P SmallCap 600 Deletion TreeHouse Foods THS Consumer Staples ABOUT S&P DOW

    2/6/26 6:24:00 PM ET
    $MBIN
    $SPGI
    $THS
    Major Banks
    Finance
    Finance: Consumer Services
    Packaged Foods

    $DLB
    $REG
    $SPGI
    $STAA
    Financials

    Live finance-specific insights

    View All

    STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results

    Confident in China Progress and Future Roadmap A Clear Path Toward Sustainable Profitability and Growth Board and Leadership Transitions Support Strategy Execution and Shareholder Value Creation STAAR Interim co-CEOs Issue Letter to Shareholders Earnings Call and Webcast Today at 5:30 PM Eastern STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal year ended January 2, 2026. STAAR's Interim co-CEOs will be issuing a Letter to Shareholders after this earnings release, which can be found here: https://investors.staar.com/new

    3/3/26 4:01:00 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the fourth quarter and fiscal year ended January 2, 2026, on Tuesday, March 3 after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and business progress. Event: STAAR Surgical Fourth Quarter and Fiscal Year 2025 Financial Results Webcast Date: Tuesday, March 3, 2026 Time: 5:30 p.m. ET/ 2:30 p.m. PT Location: https://event.choruscall.com/mediaframe/webcast.html?webcastid=J3bNAuVd Topics on the c

    2/23/26 4:01:00 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    S&P Global Reports Fourth Quarter and Full-Year 2025 Results

    NEW YORK, Feb. 10, 2026 /PRNewswire/ -- S&P Global (NYSE:SPGI) today reported fourth quarter and full-year 2025 results. The Company's earnings release and supplemental materials are available at http://investor.spglobal.com/Quarterly-Earnings.  Supplemental Information/Conference Call/Webcast Details:  The Company's senior management will review the fourth quarter and full-year 2025 earnings results on a conference call scheduled for today, February 10, at 8:30 a.m. ET. Additional information presented on the conference call, and the Company's supplemental slide content may b

    2/10/26 7:22:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $DLB
    $REG
    $SPGI
    $STAA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Regency Centers Corporation

    SC 13G - REGENCY CENTERS CORP (0000910606) (Subject)

    11/14/24 1:22:37 PM ET
    $REG
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

    SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

    11/13/24 4:05:17 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    SEC Form SC 13G filed by Regency Centers Corporation

    SC 13G - REGENCY CENTERS CORP (0000910606) (Subject)

    10/15/24 1:39:07 PM ET
    $REG
    Real Estate Investment Trusts
    Real Estate